LYON, France and CAMBRIDGE, Mass., Feb. 11, 2022 (GLOBE NEWSWIRE) Amolyt Pharma, a global company specialized in developing therapeutic peptides for rare endocrine and related diseases, today announced
The French Tech 120 list represents the 120 top performing and rapidly growing startups based in France across all industries, including 7 biotechnology.